Skip to main content

Zebrafish on drugs

In the November 21 Proceedings of the National Academy of Sciences, Peterson et al. describe a screen for chemicals that can be used to interfere with, and time, developmental events in zebrafish (Proc Natl Acad Sci USA 2000, 97:12965-12969). Zebrafish eggs were arrayed three to a well in 96-well plates, along with one of 1,100 synthetic small molecules. The developing embryos were screened once a day for three days for defects in the central nervous system, the cardiovascular system, pigmentation, or ear development, with one person capable of screening approximately 400 compounds a day. Approximately 2% of the compounds were generally lethal or caused widespread necrosis, but approximately 1% of the compounds affected a specific aspect of one system under study. Peterson et al. demonstrated the utility of such probes by adding and washing away a particular chemical at different times, thus determining that a critical stage for ear development occurs between 14 and 26 hours post-fertilization. Further insight may come from isolation of the proteins targeted by the chemicals, using procedures such as affinity chromatography.

References

  1. 1.

    Proceedings of the National Academy of Sciences, [http://www.pnas.org/]

  2. 2.

    Target-oriented and diversity-oriented organic synthesis in drug discovery.

  3. 3.

    Chemistry or biology: which comes first after the genome is sequenced?

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wells, W. Zebrafish on drugs. Genome Biol 1, spotlight-20001122-02 (2000). https://doi.org/10.1186/gb-spotlight-20001122-02

Download citation

Keywords

  • Nervous System
  • Central Nervous System
  • Small Molecule
  • Cardiovascular System
  • Affinity Chromatography